Cargando…
Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing
Irreversible electroporation (IRE) is used clinically as a focal therapy to ablate solid tumors. A critical disadvantage of IRE as a monotherapy for cancer is the inability of ablating large tumors, because the electric field strength required is often too high to be safe. Previous reports indicate...
Autores principales: | Hanson, Samuel M., Forsyth, Bruce, Wang, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144369/ https://www.ncbi.nlm.nih.gov/pubmed/34031433 http://dx.doi.org/10.1038/s41598-021-89661-y |
Ejemplares similares
-
Tumor Ablation with Irreversible Electroporation
por: Al-Sakere, Bassim, et al.
Publicado: (2007) -
Irreversible electroporation on the small intestine
por: Phillips, M A, et al.
Publicado: (2012) -
Irreversible electroporation: state of the art
por: Wagstaff, Peter GK, et al.
Publicado: (2016) -
Irreversible Electroporation for Prostate Cancer
por: Ong, Sean, et al.
Publicado: (2021) -
Local Release of TGF‐β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy
por: Peng, Huiming, et al.
Publicado: (2022)